Viridian Therapeutics, Inc./DE Realized Investment Gains (Losses)
Viridian Therapeutics, Inc./DE (VRDN) reported Realized Investment Gains (Losses) of $4.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-07.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RealizedInvestmentGainsLosses · last filed 2021-11-05
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for the quarter ending 2021-03-31 was $4.00K.
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for the quarter ending 2020-12-31 was $0.00.
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for the quarter ending 2020-09-30 was $0.00.
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for the quarter ending 2020-06-30 was $0.00.
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for fiscal 2020 was $0.00.
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for fiscal 2019 was $0.00.
- Viridian Therapeutics, Inc./DE realized investment gains (losses) for fiscal 2018 was $0.00.
| Period end | Realized Investment Gains (Losses) 3 month | Realized Investment Gains (Losses) 6 month | Realized Investment Gains (Losses) 9 month | Realized Investment Gains (Losses) 12 month |
|---|---|---|---|---|
| 2021-03-31 | $4.00K 10-Q · filed 2021-05-07 | $4.00K derived: sum of 2 quarters · filed 2021-05-07 | $4.00K derived: sum of 3 quarters · filed 2021-11-05 | $4.00K derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 derived: sum of 3 quarters · filed 2021-11-05 | $0.00 10-K · filed 2021-03-26 |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-05 | $0.00 derived: sum of 2 quarters · filed 2021-11-05 | $0.00 10-Q · filed 2021-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-11-05 |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-12 | $0.00 10-Q · filed 2021-08-12 | $0.00 derived: sum of 3 quarters · filed 2021-08-12 | $0.00 derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-05-07 | $0.00 derived: sum of 3 quarters · filed 2021-05-07 | $0.00 derived: sum of 4 quarters · filed 2021-05-07 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | $0.00 derived: sum of 2 quarters · filed 2021-03-26 | $0.00 derived: sum of 3 quarters · filed 2021-03-26 | $0.00 10-K · filed 2021-03-26 |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-05 | $0.00 10-Q · filed 2020-08-05 | $0.00 derived: sum of 3 quarters · filed 2020-08-05 | $0.00 derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-08 | $0.00 derived: sum of 2 quarters · filed 2020-05-08 | $0.00 derived: sum of 3 quarters · filed 2020-05-08 | $0.00 derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $0.00 derived: sum of 2 quarters · filed 2020-03-13 | $0.00 derived: sum of 3 quarters · filed 2020-03-13 | $0.00 10-K · filed 2020-03-13 |
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | $0.00 derived: sum of 2 quarters · filed 2019-11-08 | $0.00 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |